Two studies by researchers at the Translational Genomics Research Institute (TGen) and the University of North Carolina Lineberger Comprehensive Cancer Center (UNC Lineberger) provide insight on the evolution of glioblastoma ...
May 3, 2017
0
4
A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy and an approved chemotherapy showed the combination to be well tolerated while also resulting in unexpectedly ...
Apr 14, 2017
2
280
UCLA researchers have discovered that combining a vaccine developed at UCLA with other experimental therapies and FDA-approved treatments shows promise for reducing the size of advanced brain tumors. The immunotherapy, which ...
Jan 25, 2017
0
2
In experiments on mice with a form of aggressive brain cancer, Johns Hopkins researchers have shown that localized chemotherapy delivered directly to the brain rather than given systemically may be the best way to keep the ...
Dec 22, 2016
0
58
A subgroup of patients with a devastating brain tumor called glioblastoma multiforme benefited from treatment with a class of chemotherapy drugs that two previous large clinical trials indicated was ineffective against the ...
Dec 22, 2016
0
0
While a particular metabolic pathway shows potential to slow down the aging process, new research indicates a downside: That same pathway may drive brain cancer.
Dec 6, 2016
0
172
Glioblastoma multiforme remains the most common and highly lethal brain cancer and is known for its ability to relapse. Researchers at The University of Texas MD Anderson Cancer Center have identified a pathway by which cancer ...
Nov 17, 2016
0
2
Every year, about 60 children and adolescents in Germany are diagnosed with glioblastoma, a very aggressive type of brain cancer, which is still mostly untreatable. Now, scientists from the Max Planck Institute for Molecular ...
Oct 20, 2016
0
31
Radiomics, an approach that combines imaging and computation, can stratify patients with recurrent glioblastoma into those who are likely to benefit from the antiangiogenic therapy bevacizumab (Avastin) and those who do not, ...
Oct 11, 2016
0
1
Privately insured people with two types of cancer were diagnosed earlier and lived longer than those who were uninsured or were covered by Medicaid, according to two new studies.
Sep 23, 2016
0
2
